Activation marker F1+2 in patients treated with recombinant factor VIIa

被引：0
|
作者：
Ingerslev, J
Holm, M
Christiansen, K
Knudsen, L
机构：
[1] AARHUS UNIV HOSP, DEPT CLIN IMMUNOL, CTR HAEMOPHILIA & THROMBOSIS, DK-8200 AARHUS N, DENMARK
[2] AARHUS UNIV HOSP, DEPT HAEMATOL, DK-8200 AARHUS N, DENMARK
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：PS344 / PS344
页数：1
相关论文
共 50 条
  • [41] THE SAFETY OF RECOMBINANT FACTOR-VIIA (RFVIIA) IN ACENOCOUMAROL TREATED VOLUNTEERS - A PHASE-1 STUDY
    ERHARDTSEN, E
    NONY, P
    FFRENCH, P
    DECHAVANNE, M
    BOISSEL, JP
    LYNG, HL
    HEDNER, U
    GLAZER, S
    BLOOD, 1994, 84 (10) : A67 - A67
  • [42] Coagulation factor VIIa (recombinant) in nonhemophilic patients requiring neurosurgery
    Culley, Colleen A.
    Guttendorf, Susan
    Coldren, Megan
    Skledar, Susan J.
    Gross, Paige R.
    Spiro, Richard M.
    Triulzi, Darrell J.
    Ragni, Margaret V.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (17) : 1554 - 1559
  • [43] Intensive Menstrual Bleeding Successfully Treated With Recombinant Factor VIIa in Glanzmann Thrombasthenia
    Balci, Yasemin Isik
    Karabulut, Aysun
    Kabukcu, Sibel
    Sari, Ismail
    Keskin, Ali
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2011, 17 (04) : 320 - 322
  • [44] GEMFIBROZIL REDUCES PLASMA PROTHROMBIN FRAGMENT F1+2 CONCENTRATION, A MARKER OF COAGULABILITY, IN PATIENTS WITH CORONARY HEART-DISEASE
    WILKES, HC
    MEADE, TW
    BARZEGAR, S
    FOLEY, AJ
    HUGHES, LO
    BAUER, KA
    ROSENBERG, RD
    MILLER, GJ
    THROMBOSIS AND HAEMOSTASIS, 1992, 67 (05) : 503 - 506
  • [45] Activation and aggregation of platelets to leukocytes in whole blood by recombinant factor VIIa.
    Wilbourn, BR
    Harrison, P
    Mackie, IS
    Liesner, R
    Hann, I
    Machin, SJ
    BLOOD, 2001, 98 (11) : 48B - 48B
  • [46] F1+2 AND TAT LEVELS IN PATIENTS WITH INHERITED APC-RESISTANCE
    SCARANO, L
    SIMIONI, P
    GAVASSO, S
    SARDELLA, C
    ROSSI, L
    SCUDELLER, A
    GIROLAMI, A
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1366 - 1366
  • [47] Use of recombinant factor VIIa in surgery in factor-VII-deficient patients
    Ingerslev, J
    Knudsen, L
    Hvid, I
    Tange, MR
    Fredberg, U
    Sneppen, O
    HAEMOPHILIA, 1997, 3 (03) : 215 - 218
  • [48] Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency
    Scharrer, I
    HAEMOPHILIA, 1999, 5 (04) : 253 - 259
  • [49] THE ACTIVATION OF FACTOR-X AND PROTHROMBIN BY RECOMBINANT FACTOR VIIA IN-VIVO IS MEDIATED BY TISSUE FACTOR
    TENCATE, H
    BAUER, KA
    LEVI, M
    EDGINGTON, TS
    SUBLETT, RD
    BARZEGAR, S
    KASS, BL
    ROSENBERG, RD
    JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (03): : 1207 - 1212
  • [50] ISOLATION AND CHARACTERIZATION OF A SPECIFIC ANTIBODY POPULATION DIRECTED AGAINST THE PROTHROMBIN ACTIVATION FRAGMENTS F2 AND F1+2
    LAU, HK
    ROSENBERG, JS
    BEELER, DL
    ROSENBERG, RD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1979, 254 (18) : 8751 - 8761
12345